Verge Genomics Company
CONVERGE®: An "all-in-human" genomics platform used to map neurodegenerative diseases and identify novel targets.
Investors
.png)
Connections from
Industry:
Early Drug Development
Headquarters:
USA
Total Funding:
$130M
Founded Date:
2015